The Quality Lowdown: Pandemic Site Evaluation Creativity On Display As COVID Clampdown Returns

With a virtual visit to SciVac in Israel, a belated Revance site inspection in California and two weeks at a Dr. Reddy’s site in India, the US FDA finds ways to overcome travel restrictions in its efforts to oversee drug manufacturing quality.

The Quality Lowdown

More from Approval Standards

More from Pathways & Standards